Sale!

LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the LMNA gene responsible for this rare inherited neuromuscular disorder. Using next-generation sequencing technology, this test provides comprehensive analysis of the LMNA gene to detect pathogenic variants that cause progressive muscle weakness, joint contractures, and cardiac complications. The test is essential for individuals experiencing early-onset muscle weakness, joint stiffness, or those with a family history of muscular dystrophy. Results provide crucial information for accurate diagnosis, treatment planning, and genetic counseling. Available for only $500 USD, this advanced genetic test offers valuable insights for managing this complex condition and making informed family planning decisions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 NGS Genetic DNA Test

Comprehensive Genetic Testing for Rare Neuromuscular Disorders

The LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 NGS Genetic DNA Test represents a significant advancement in the diagnosis and management of rare inherited neuromuscular conditions. This specialized genetic test utilizes cutting-edge next-generation sequencing technology to analyze the LMNA gene, which plays a critical role in maintaining nuclear structure and function in muscle cells. When mutations occur in this gene, they can lead to the development of Emery-Dreifuss muscular dystrophy type 2, a progressive condition characterized by muscle weakness, joint contractures, and cardiac complications.

What This Advanced Genetic Test Detects

Our comprehensive NGS-based test specifically targets the LMNA gene to identify pathogenic variants responsible for Emery-Dreifuss muscular dystrophy type 2. The test examines:

  • Point mutations, deletions, and insertions in the LMNA gene
  • Autosomal dominant inheritance patterns
  • Genetic variants affecting lamin A/C protein production
  • Mutations that disrupt nuclear membrane integrity in muscle cells
  • Genetic markers associated with progressive muscle degeneration

Who Should Consider This Genetic Test?

Clinical Indications and Symptoms

This specialized genetic test is recommended for individuals experiencing:

  • Early-onset muscle weakness, typically appearing in childhood or adolescence
  • Progressive joint contractures, especially in elbows, ankles, and neck
  • Cardiac conduction abnormalities or arrhythmias
  • Family history of muscular dystrophy or sudden cardiac death
  • Unexplained progressive muscle wasting
  • Difficulty with mobility and physical activities
  • Muscle stiffness and reduced range of motion

Significant Benefits of Genetic Testing

Comprehensive Diagnostic Advantages

Undergoing the LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 NGS Genetic DNA Test provides numerous critical benefits:

  • Accurate Diagnosis: Provides definitive genetic confirmation of EDMD2
  • Early Intervention: Enables proactive management of symptoms
  • Cardiac Monitoring: Identifies individuals at risk for heart complications
  • Family Planning: Offers valuable information for reproductive decisions
  • Personalized Treatment: Guides targeted therapeutic approaches
  • Genetic Counseling: Supports informed family discussions
  • Clinical Trial Eligibility: May qualify patients for research studies

Understanding Your Test Results

Comprehensive Result Interpretation

Your genetic test results will be thoroughly explained by our expert genetic counselors:

  • Positive Result: Indicates the presence of a pathogenic LMNA gene mutation confirming EDMD2 diagnosis
  • Negative Result: Suggests no detectable LMNA mutation, though clinical follow-up may be recommended
  • Variant of Uncertain Significance: Identifies genetic changes requiring further investigation
  • Carrier Status: Determines inheritance patterns for family members

All results include detailed clinical correlation and recommendations for ongoing management and monitoring.

Test Information and Pricing

Test Component Details
Test Name LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before scheduling your test, please ensure you have:

  • Complete clinical history of the patient
  • Scheduled genetic counseling session
  • Family pedigree chart documenting affected relatives
  • Relevant medical records and previous test results

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic testing facilities ensures accurate and reliable results nationwide.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about your genetic health prevent you from getting the answers you need. Our specialized LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 NGS Genetic DNA Test provides the comprehensive genetic analysis required for accurate diagnosis and informed medical decisions.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take control of your neurological health journey.

Our team of genetic specialists and neurologists is ready to guide you through the testing process and provide the expert interpretation and support you deserve. Book your test now and gain the genetic insights needed for better health management and peace of mind.